Quantitative Methylation Profiles for Multiple Tumor Suppressor Gene Promoters in Salivary Gland Tumors
Open Access
- 26 May 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (5) , e10828
Abstract
Methylation profiling of tumor suppressor gene (TSGs) promoters is quickly becoming a powerful diagnostic tool for the early detection, prognosis, and even prediction of clinical response to treatment. Few studies address this in salivary gland tumors (SGTs); hence the promoter methylation profile of various TSGs was quantitatively assessed in primary SGT tissue to determine if tumor-specific alterations could be detected. DNA isolated from 78 tumor and 17 normal parotid gland specimens was assayed for promoter methylation status of 19 TSGs by fluorescence-based, quantitative methylation-specific PCR (qMSP). The data were utilized in a binary fashion as well as quantitatively (using a methylation quotient) allowing for better profiling and interpretation of results. The average number of methylation events across the studied genes was highest in salivary duct carcinoma (SDC), with a methylation value of 9.6, compared to the normal 4.5 (pAPC, Mint 1, PGP9.5, RAR-β, and Timp3. Screening promoter methylation profiles in SGTs showed considerable heterogeneity. The methylation status of certain markers was surprisingly high in even normal salivary tissue, confirming the need for such controls. Several TSGs were found to be associated with malignant SGTs, especially SDC. Further study is needed to evaluate the potential use of these associations in the detection, prognosis, and therapeutic outcome of these rare tumors.Keywords
This publication has 51 references indexed in Scilit:
- Quantitative Promoter Hypermethylation Analysis of Cancer-Related Genes in Salivary Gland Carcinomas: Comparison with Methylation-Specific PCR Technique and Clinical SignificanceClinical Cancer Research, 2008
- Tissue Inhibitor of Metalloproteinases-3 Promoter Methylation is an Independent Prognostic Factor for Bladder CancerJournal of Urology, 2008
- TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomasJournal of Cellular Physiology, 2006
- Salivary glands carcinomas, paranasal sinus cancers and melanoma of the head and neck: an update about rare but challenging tumorsCurrent Opinion in Oncology, 2006
- Silencing of the UCHL1 gene in human colorectal and ovarian cancersInternational Journal of Cancer, 2006
- Methylation Profiling of Archived Non–Small Cell Lung Cancer: A Promising Prognostic SystemClinical Cancer Research, 2005
- PGP9.5 Promoter Methylation Is an Independent Prognostic Factor for Esophageal Squamous Cell CarcinomaCancer Research, 2005
- Promoter methylation and protein expression of the E-cadherin gene in the clinicopathologic assessment of adenoid cystic carcinomaLaboratory Investigation, 2004
- Expression of p16 Protein and Hypermethylation Status of Its Promoter Gene in Adenoid Cystic Carcinoma of the Head and NeckORL, 2003
- Methylation status in the promoter region of the human PGP9.5 gene in cancer and normal tissuesCancer Letters, 2001